Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Israel-Hamas truce extended
Six-planet solar system found
Diagnosed with concussion
Missing woman found dead
'Godfather of Harlem' S4
Renewed for S2 at NBC
Returning to host ‘SNL’
Aide to join Trump campaign
Suspended for misconduct
Online news sharing deal
13 killed in hostel fire
Warship shoots down drone
To play young Donald Trump
Tony-winning actress dies
Dairy-free mac & cheese
Disney’s new board members
Honors Matthew Perry
Blinken arrives in Israel
Joins OpenAI’s board
Disney CEO to step down
Henry Kissinger dies
Hits back at advertisers
16 more hostages freed
Worker dragged under train
'Ted' series trailer
Ending w/ season 5 on CBS
Panthers sign Jackson
Nixon joins hunger strike
Killed wife over cat's vet care
Finland closes RU border
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
905 results
Health Affairs
1d
Arriving At A Fair Price In The Medicare Drug Price Negotiation Program: Considerations From Other Countries
The drug pricing paradigms of Canada, France, and Germany offer lessons for the United States on how to arrive at a “fair ...
Commonwealth Fund
16h
How Drug Price Reforms in the Inflation Reduction Act Could Impact States
Legislative solutions to the prescription drug price issue were slow to materialize until the Inflation Reduction Act changed ...
JD Supra3d
Are Drugmakers Gaming the Patent System?
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
5d
Novartis Urges Court to Hand It Quick Win in Drug Price Battle
Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said in ...
STAT1d
White House official dings Bristol Myers Squibb for fighting off generic competition
WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a drugmaker fighting the administration’s ...
Fierce Healthcare21d
CMS wants feedback on how Medicare drug negotiations should evolve. Researchers, advocates, drugmakers all have notes
In terms of therapeutic breakthroughs, Isasi suggested that the drug price negotiation program’s current structure is an effective deterrent from drugmakers’ low-impact profit chasing. “In ...
Fierce Healthcare23d
Trump, Biden HHS chiefs clash over impact of Medicare drug price negotiations
Two health secretaries from the Trump and Biden administrations agree that bringing down high drug costs is a critical priority to make healthcare more affordable for patients. But they have far ...
12don MSN
The inescapable ad campaign for a wonky drug policy debate
A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a ...
HealthLeaders Media21d
Patient Advocates Rap 'Greedy' PhRMA IRA Lawsuits
As consumers struggle with soaring drug prices, AstraZeneca Q3 profits doubled to $1.37 billion. The pharmaceutical industry is enjoying record profits while simultaneously pursuing lawsuits ...
FiercePharma23d
With Amgen's biosim on the scene, J&J's Stelara looks poised to sidestep Medicare negotiations: HHS
There might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an ...
Wausau Pilot and Review
2d
When will Wisconsinites see relief from high drug prices? A health insurance broker weighs in
Wisconsin Public Radio This year, Medicare will start negotiating lower prescription drug prices. But one Wisconsin insurance broker ...
Politico22d
A crackdown on Medicare Advantage plan sales
TAMING HEALTH CARE ‘MIDDLEMEN’ — The Biden administration wants to cap the amount insurers can pay Medicare Advantage brokers and agents per enrollee, POLITICO’s Robert King reports.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices